Answers are grounded in this paper and cite their sources.
This approach demonstrates regioselective and chemoselective alkylation in quinolin-4-ones, indicating precise control over outcomes using unique catalysts and conditions.
Condition-switchable, regiodivergent O-, N-, and C-allylation of quinolin-4-ones with Morita-Baylis-Hillman (MBH) carbonates is disclosed. Systematic modulation of the Lewis/Brønsted base catalyst and solvent enables programmable site-selectivity: γ-O-allylation proceeds exclusively under condition A (10 mol % DABCO, CH₂Cl₂, 25 °C), whereas α-O-allylation is favored under condition B (10 mol % K₂CO₃, DMF, 80 °C); subsequently, N1- and C3-allylations are achieved under condition C (20 mol % DMAP, t-BuOH, 80 °C) and conditions D (10 mol % DABCO, DCE, 100 °C), respectively. The protocol features broad substrate scope, high yields (up to 99%), and excellent selectivity. Mechanistic studies support O-to-N and O-to-C rearrangement pathways for N1- and C3-products, respectively. This operationally simple method provides a practical platform for late-stage diversification of medicinally relevant quinolin-4-ones.
No takes yet. Share an insight, caveat, or question.
Chunling Lu (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: